Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
---|---|---|---|---|---|---|
1 | All patients in the study will be treated with ocrelizumab (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
2 | Continued Ocrelizumab (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
3 | OCRELIZUMAB (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 13 13, 46, 49 |
4 | Ocrelizumab (CinnaGen, Iran) (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
5 | Ocrelizumab (Roche, Switzerland) (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
6 | Ocrelizumab / rhuMAb 2H7 (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
7 | Ocrelizumab 300 mg (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
8 | Ocrelizumab 300mg (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
9 | Ocrelizumab 300mg /10ml (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
10 | Ocrelizumab 300mg/10 ml (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
11 | Ocrelizumab 300mg/10ml (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
12 | Ocrelizumab 500mg (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
13 | Ocrelizumab 600 mg (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
14 | Ocrelizumab at home (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
15 | Ocrelizumab Dose 1 (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
16 | Ocrelizumab Dose 2 and Dose 3 (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
17 | Ocrelizumab IV (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
18 | Ocrelizumab SC (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
19 | Other: Observation of Ocrelizumab as Treatment in RRMS Patients (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
20 | Other: Ocrelizumab (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
21 | Short-course Ocrelizumab (Synonym: D05218) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |